Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy

Authors: Rosenberg, Jonathan E., Mamtani, Ronac, Sonpavde, Guru P., Loriot, Yohann, Duran, Ignacio, Lee, Jae-Lyun, Matsubara, Nobuaki, Vulsteke, Christof, Castellano, Daniel, Sridhar, Srikala S., Pappot, Helle, Gurney, Howard, Bedke, Jens, van der Heijden, Michiel S., Galli, Luca, Keam, Bhumsuk, Masumori, Naoya, Meran, Johannes, O'Donnell, Peter H., Park, Se Hoon, Grande, Enrique, Sengeløv, Lisa, Uemura, Hiroji, Skaltsa, Konstantina, Campbell, Mary, Matsangou, Maria, Wu, Chunzhang, Hepp, Zsolt, McKay, Caroline, Powles, Thomas, Petrylak, Daniel P.

Source: In European Urology June 2024 85(6):574-585

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Authors: Park, Se Hoon, van der Heijden, Michiel S., Necchi, Andrea, Castellano, Daniel, Bamias, Aristotelis, Lee, Jae Lyun, De Giorgi, Ugo, Bögemann, Martin, Eigl, Bernhard J., Tsiatas, Marinos, Powles, Thomas, Novikov, Andrey, Skoneczna, Iwona, Mukherjee, Som D., Suarez, Cristina, Westgeest, Hans, Fradet, Yves, Flechon, Aude, Ou, Yen-Chuan, Park, Inkeun, Matveev, Vsevolod, Pérez-Valderrama, Begoña, Cheng, Susanna, Frank, Stephen, Gurney, Howard, Anido, Urbano, Hamzaj, Alketa, Retz, Margitta, Sridhar, Srikala, Scagliotti, Giorgio Vittorio, Voortman, Jens, Alekseev, Boris, Alyasova, Anna, Komyakov, Boris, Dumez, Herlinde, Pavic, Michel, Kimura, Go, Mizokami, Atsushi, Osanto, Susanne, Arranz, Jose Angel, Piersma, Djura, Shin, Sang Joon, Karyakin, Oleg, Delgado, Ignacio, Gonzalez, Jose Luis, Pang, See-Tong, Tran, Anna, Lipatov, Oleg, Su, Wen-Pin, Flaig, Thomas, Alva, Ajjai, Park Kyong, Hwa, Kopyltsov, Evgeny, Almagro, Elena, Domenech, Monserrat, Chang, Yen-Hwa, Sautois, Brieuc, Ravaux, Andre, Aravantinos, Gerasimos, Georgoulias, Vasileios, Mulder, Sasja, Kim, Yu Jung, Kater, Fabio, Chevreau, Christine, Tagawa, Scott, Zalewski, Pawel, Joly, Florence, Loriot, Yohann, Hatiboglu, Gencay, Gianni, Luca, Morelli, Franco, Tambaro, Rosa, Hashimoto, Yasuhiro, Nosov, Alexander, Font, Albert, Rodriguez-Vida, Alejo M., Jones, Robert, Vasudev, Naveen, Srinivas, Sandhya, Zhang, Jingsong, Gil, Thierry, Finch, Daygen, Grimm, Marc-Oliver, Su, Yu-Li, Chowdhury, Simon, Hocking, Christopher, Plas, Eugen, North, Scott, Jensen, Niels Viggo, Theodore, Christine, Imkamp, Florian, Peer, Avivit, Kobayashi, Takashi, Sakai, Hideki, Sassa, Naoto, Yoshimura, Kazuhiro, Aarts, Maureen, Ferreira Castro, Ana, Topuzov, Marlen, Rodriguez, Juan Francisco, Vazquez, Federico Jose, Tsai, Yu-Chieh, Crabb, Simon, Hussain, Syed, Bendell, Johanna, Gross-Goupil, Marine, Gwenaelle, Gravis, Berger, Raanan, Statsenko, Galina, Evans, Linda, Drakaki, Alexandra, Somer, Bradley, Davis, Ian, Lynam, James, Borges, Giuliano, Dettino, Aldo, Fay, André P., Martins, Graziella, Zucca, Luis Eduardo, Agerbaek, Mads, Kalofonos, Haralambos, Rosenbaum, Eli, Enokida, Hideki, Kikukawa, Hiroaki, Nishimura, Kazuo, Tamada, Satoshi, Uemura, Motohide, Lopez, Yamil, Gietema, Jourik, Slojewski, Marcin, Fernandes, Isabel, Smolin, Alexey, Mazhar, Danish, Kalebasty, Arash Rezazadeh, Carthon, Bradley, Loidl, Wolfgang, Franke, Fabio, Girotto, Gustavo, Alimohamed, Nimira, Macfarlane, Robyn, Pappot, Helle, Niegisch, Guenter, Mavroudis, Dimitrios, Sella, Avishay, Porta, Camillo, Ebara, Shin, Nakamura, Motonobu, Obara, Wataru, Okuno, Norihiko, Shinohara, Nobuo, Sugimoto, Mikio, Suzuki, Akitaka, Tokuda, Noriaki, Uemura, Hiroji, Yamaguchi, Akito, Ramirez, Francisco, Rozanowski, Pawel, Wiechno, Pawel, Keam, Bhumsuk, Kislov, Nikolay, Plaksin, Denis, Cicin, Irfan, Kumar, Satish, Galsky, Matthew D., Petrylak, Daniel P., Rosales, Joseph, Vaishampayan, Ulka, Culine, Stephane, Papandreou, Christos, Nara, Taketoshi, Erman, Mustafa, Kreiger, Laurence, Janoski, Juliana, Rosa, Diogo, Siqueira, Mariana, Canil, Christina, Sengelov, Lisa, Tourani, Jean-Marc, Arai, Gaku, Hashine, Katsuyoshi, Kawakita, Mutsushi, Nakaigawa, Noboru, Nomi, Hayahito, Shiina, Hiroaki, Suzuki, Hiroyoshi, Yonese, Junji, Kuri, Roberto, Macedo, Eleazar, Rivera, Samuel, Villalobos Prieto, Alberto, Polakiewicz-Gilowska, Anna, Zaucha, Renata, Lopes, Fabio, Ponomarev, Roman, Pomerantz, Mark, Shariat, Shahrokh, Luk, Cynthia, Lesniewski-Kmak, Krzysztof, van der Heijden, Michiel S, Galsky, Matthew D, Petrylak, Daniel P, Ogawa, Osamu, Lee, Jae-Lyun, Eigl, Bernhard J, Mukherjee, Som D, Suárez, Cristina, Fay, André P, Duran, Ignacio, Wildsmith, Sophie, He, Philip, Angra, Natasha, Gupta, Ashok K, Levin, Wendy, Bellmunt, Joaquim

Source: In The Lancet Oncology December 2020 21(12):1574-1588

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

Authors: Fizazi, Karim, Drake, Charles G., Beer, Tomasz M., Kwon, Eugene D., Scher, Howard I., Gerritsen, Winald R., Bossi, Alberto, den Eertwegh, Alfons J.M. van, Krainer, Michael, Houede, Nadine, Santos, Ricardo, Mahammedi, Hakim, Ng, Siobhan, Danielli, Riccardo, Franke, Fabio A., Sundar, Santhanam, Agarwal, Neeraj, Bergman, André M., Ciuleanu, Tudor E., Korbenfeld, Ernesto, Sengeløv, Lisa, Hansen, Steinbjorn, McHenry, M. Brent, Chen, Allen, Logothetis, Christopher

Source: In European Urology December 2020 78(6):822-830

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial

Authors: Ahlgren, Göran M., Flodgren, Per, Tammela, Teuvo L.J., Kellokumpu-Lehtinen, Pirkko, Borre, Michael, Angelsen, Anders, Iversen, Jon Reidar, Sverrisdottir, Asgerdur, Jonsson, Eirikur, Sengelov, Lisa

Source: In European Urology June 2018 73(6):870-876

Improving information to caregivers of cancer patients: the Herlev Hospital Empowerment of Relatives through More and Earlier information Supply (HERMES) randomized controlled trial

Authors: Lund, Line, Ross, Lone, Petersen, Morten Aagaard, Sengelov, Lisa, Groenvold, Mogens

Source: Supportive care in cancer. 28(2):939-950

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125848073.0x000001&indx=1&recIds=ETOCvdc_100125848073.0x000001

Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer

Authors: Kongsted, Per, Svane, Inge Marie, Lindberg, Henriette, Sengeløv, Lisa

Source: In Clinical Genitourinary Cancer April 2017 15(2):e281-e287

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

Authors: Kongsted, Per ^*, Borch, Troels Holz ^*, Ellebaek, Eva, Iversen, Trine Zeeberg, Andersen, Rikke, Met, Özcan, Hansen, Morten, Lindberg, Henriette, Sengeløv, Lisa, Svane, Inge Marie ^*

Source: In Cytotherapy April 2017 19(4):500-513

Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer

Authors: Kongsted, Per, Svane, Inge Marie, Lindberg, Henriette, Sengeløv, Lisa

Source: In Clinical Genitourinary Cancer December 2016 14(6):e559-e568

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Authors: Sternberg, Cora N, Skoneczna, Iwona, Kerst, J Martijn, Albers, Peter, Fossa, Sophie D, Agerbaek, Mads, Dumez, Herlinde, de Santis, Maria, Théodore, Christine, Leahy, Michael G, Chester, John D, Verbaeys, Antony, Daugaard, Gedske, Wood, Lori, Witjes, J Alfred, de Wit, Ronald, Geoffrois, Lionel, Sengelov, Lisa, Thalmann, George, Charpentier, Danielle, Rolland, Frédéric, Mignot, Laurent, Sundar, Santhanam, Symonds, Paul, Graham, John, Joly, Florence, Marreaud, Sandrine, Collette, Laurence, Sylvester, Richard

Source: In Lancet Oncology January 2015 16(1):76-86

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Authors: Kwon, Eugene D, Drake, Charles G, Scher, Howard I, Fizazi, Karim, Bossi, Alberto, van den Eertwegh, Alfons J M, Krainer, Michael, Houede, Nadine, Santos, Ricardo, Mahammedi, Hakim, Ng, Siobhan, Maio, Michele, Franke, Fabio A, Sundar, Santhanam, Agarwal, Neeraj, Bergman, Andries M, Ciuleanu, Tudor E, Korbenfeld, Ernesto, Sengeløv, Lisa, Hansen, Steinbjorn, Logothetis, Christopher, Beer, Tomasz M, McHenry, M Brent, Gagnier, Paul, Liu, David, Gerritsen, Winald R

Source: In The Lancet Oncology June 2014 15(7):700-712

Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme

Authors: Heidenreich, Axel, Bracarda, Sergio, Mason, Malcolm, Ozen, Haluk, Sengelov, Lisa, Van Oort, Inge, Papandreou, Christos, Fossa, Sophie, Hitier, Simon, Climent, Miguel Angel

Source: In European Journal of Cancer April 2014 50(6):1090-1099

Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: Is there a clinical benefit?

Authors: Kongsted, Per, Svane, Inge Marie, Lindberg, Henriette, Daugaard, Gedske, Sengeløv, Lisa

Source: In Urologic Oncology: Seminars and Original Investigations November 2015 33(11):494-494

Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies

Authors: Als, Anne Birgitte, Sengelov, Lisa, von der Maase, Hans

Source: In European Urology August 2007 52(2):478-487

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

Authors: Hoyer, Morten, Roed, Henrik, Sengelov, Lisa, Traberg, Anders, Ohlhuis, Lars, Pedersen, Jorgen, Nellemann, Hanne, Kiil Berthelsen, Anne, Eberholst, Frey, Engelholm, Svend Aage, von der Maase, Hans

Source: In Radiotherapy and Oncology July 2005 76(1):48-53

Response to Letter to the Editor: Improving information to caregivers of cancer patients: the Herlev Hospital Empowerment of Relatives through More and Earlier information Supply (HERMES) randomized controlled trial

Authors: Lund, Line, Ross, Lone, Petersen, Morten Aagaard, Sengelov, Lisa, Groenvold, Mogens

Source: Supportive care in cancer. 28(2):417-417

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125847996.0x000001&indx=1&recIds=ETOCvdc_100125847996.0x000001

The functional and psychosocial status of patients with disseminated bladder cancer

Authors: Sengeløv, Lisa ^*, Frølich, Søren, Kamby, Claus, Jensen, Niels Henrik, Steven, Kenneth

Source: In Urologic Oncology: Seminars and Original Investigations 2000 5(1):20-24

Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome

Authors: Sengeløv, Lisa ^*, Christensen, Mariann, von der Maase, Hans, Horn, Thomas, Marcussen, Niels, Kamby, Claus, Ørntoft, Torben

Source: In Cancer Genetics and Cytogenetics 2000 123(2):109-113

Gemcitabine and cisplatin in locally advanced and metastatic bladder cancer; 3- or 4-week schedule?

Authors: Als, Anne Birgitte¹ abals@as.aaa.dk, Sengelov, Lisa², Von Der Maase, Hans³

Source: Acta Oncologica. Jan2008, Vol. 47 Issue 1, p110-119. 10p. 7 Charts, 3 Graphs.

Subject Terms: *CISPLATIN, *ANTINEOPLASTIC agents, *BLADDER cancer, *DRUG therapy, *CANCER research

Radiotherapy in bladder cancer

Authors: Sengeløv, Lisa ^*, von der Maase, Hans

Source: In Radiotherapy and Oncology 1999 52(1):1-14

ASSESSMENT OF PATIENTS WITH METASTATIC TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT

Authors: SENGELOV, LISA, von der MAASE, HANS, KAMBY, CLAUS, JENSEN, LISE INGEMANN, RASMUSSEN, FINN, HORN, THOMAS, NIELSEN, STEEN LEVIN, STEVEN, KENNETH

Source: In The Journal of Urology 1999 162(2):343-346